Friday, August 12, 2011
Yet one nagging question remains: Will it have enough vials of an essential generic chemotherapy drug to last throughout the trial?
Threshold isn’t alone. A national shortage of key generic cancer drugs — often used in combination with treatments like Threshold’s or to provide statistical backdrops in studies — is threatening clinical trials.
The shortfall is forcing a handful of Bay Area drug developers to develop backup plans, including stockpiling supplies.